Osthole Increases the Sensitivity of Liver Cancer to Sorafenib by Inhibiting Cholesterol Metabolism

References

• Zhuang BW, Li W, Xie XH, Hu HT, Lu MD, Xie XY. Sorafenib versus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis. Jpn J Clin Oncol. 2019;49(9):845–855. doi:10.1093/jjco/hyz069
   PubMed Web of Science ®Google Scholar
• Yang QZ, Gao LH, Huang XL, Weng J, Chen YK, Lin SB, Yin QS. Sorafenib prevents the proliferation and induces the apoptosis of liver cancer cells by regulating autophagy and hypoxia-inducible factor-1. Exp Ther Med. 2021;22(3):980. doi:10.3892/etm.2021.10412
   PubMed Web of Science ®Google Scholar
• Zhang C, Jiang WQ, Ding J. New insights on sorafenib resistance in liver cancer with correlation of individualized therapy. Biochim Biophys Acta Rev Cancer. 2020;1874:188382. doi:10.1016/j.bbcan.2020.188382
   PubMed Web of Science ®Google Scholar
• Xia SJ, Pan Y, Liang YL, Xu JJ, Cai XJ. The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma. eBioMed. 2020;51:102610. doi:10.1016/j.ebiom.2019.102610
   PubMed Web of Science ®Google Scholar
• Marin JJG, Macias RIR, Monte MJ, Romero MR, Asensio M, Sanchez-Martin A, Cives-Losada C, Temprano AG, Espinosa-Escudero R, Reviejo M, et al. Molecular bases of drug resistance in hepatocellular carcinoma. Cancers. 2020;12(6):1663. doi:10.3390/cancers12061663
   PubMed Web of Science ®Google Scholar
• Niu LL, Liu LP, Yang SL, Ren JW, Lai PBS, Chen GG. New insights into sorafenib resistance in hepatocellular carcinoma: responsible mechanisms and promising strategies. Biochim Biophys Acta Rev Cancer. 2017;1868(2):564–570. doi:10.1016/j.bbcan.2017.10.002
   PubMed Web of Science ®Google Scholar
• Shokoohinia Y, Jafari F, Mohammadi Z, Bazvandi L, Hosseinzadeh L, Chow N, Bhattacharyya P, Farzaei MH, Farooqi AA, Nabavi SM, et al. Potential anticancer properties of osthole: a comprehensive mechanistic review. Nutrients. 2018;10(1):36. doi:10.3390/nu10010036
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh M, Mohammadinejad R, Samarghandian S, Yaribeygi H, Johnston TP, Sahebkar A. Anti-tumor effects of osthole on different malignant tissues: a review of molecular mechanisms. Anticancer Agents Med Chem. 2020;20(8):918–931. doi:10.2174/1871520620666200228110704
   PubMed Web of Science ®Google Scholar
• Mo YS, Wu Y, Li X, Rao H, Tian XX, Wu DN, Qiu ZP, Zheng GH, Hu JJ. Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation. Eur J Pharmacol. 2020;867:172788. doi:10.1016/j.ejphar.2019.172788
   PubMed Web of Science ®Google Scholar
• Lin ZK, Liu J, Jiang GQ, Tan G, Gong P, Luo HF, Li HM, Du J, Ning Z, Xin Y, et al. Osthole inhibits the tumorigenesis of hepatocellular carcinoma cells. Oncol Rep. 2017;37(3):1611–1618. doi:10.3892/or.2017.5403
   PubMed Web of Science ®Google Scholar
• Zhao Y, Huang H, Jia CH, Fan K, Xie T, Zhu ZY, Xie ML. Apigenin increases radiosensitivity of glioma stem cells by attenuating HIF-1α-mediated glycolysis. Med Oncol. 2021;38(11):131. doi:10.1007/s12032-021-01586-8
   PubMed Web of Science ®Google Scholar
• Wang F, Zhao Y, Fan K, Xie ML. Apigenin suppresses TGF-β1-induced cardiac fibroblast differentiation and collagen synthesis through the downregulation of HIF-1α expression by miR-122-5p. Phytomedicine. 2021;83:153481. doi:10.1016/j.phymed.2021.153481
   PubMed Web of Science ®Google Scholar
• Buechler C, Aslanidis C. Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(5):158658. doi:10.1016/j.bbalip.2020.158658
   PubMed Web of Science ®Google Scholar
• Yan AW, Jia ZR, Qiao C, Wang MS, Ding XS . Cholesterol metabolism in drug‑resistant cancer (Review). Int J Oncol. 2020;57(5):1103–1115. doi:10.3892/ijo.2020.5124
   PubMed Web of Science ®Google Scholar
• Kumar P, Devaki B, Jonnala UK, Amere Subbarao S. Hsp90 facilitates acquired drug resistance of tumor cells through cholesterol modulation however independent of tumor progression. Biochim Biophys Acta Mol Cell Res. 2020;1867(8):118728. doi:10.1016/j.bbamcr.2020.118728
   PubMed Web of Science ®Google Scholar
• Varan G, Oncul S, Ercan A, Benito JM, Mellet CO, Bilensoy E. Cholesterol-targeted anticancer and apoptotic effects of anionic and polycationic amphiphilic cyclodextrin nanoparticles. J Pharm Sci. 2016;105(10):3172–3182. doi:10.1016/j.xphs.2016.06.021
   PubMed Web of Science ®Google Scholar
• Verstraeten SL, Albert M, Paquot A, Muccioli GG, Tyteca D, Mingeot-Leclercq MP. Membrane cholesterol delays cellular apoptosis induced by ginsenoside Rh2, a steroid saponin. Toxicol Appl Pharmacol. 2018;352:59–67. doi:10.1016/j.taap.2018.05.014
   PubMed Web of Science ®Google Scholar
• Gu L, Saha ST, Thomas J, Kaur M. Targeting cellular cholesterol for anticancer therapy. Febs J. 2019;286(21):4192–4208. doi:10.1111/febs.15018
   PubMed Web of Science ®Google Scholar
• Moslehi A, Hamidi-zad Z. Role of SREBPs in liver diseases: a mini-review. J Clin Transl Hepatol. 2018;6:332–338. doi:10.14218/JCTH.2017.00061
   PubMed Web of Science ®Google Scholar
• Cheng X, Li J, Guo D. SCAP/SREBPs are central players in lipid metabolism and novel metabolic targets in cancer therapy. Curr Top Med Chem. 2018;18(6):484–493. doi:10.2174/1568026618666180523104541
   PubMed Web of Science ®Google Scholar
• Du R, Xue J, Wang HB, Zhang Y, Xie ML. Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression. Eur J Pharmacol. 2011;666(1–3):183–188. doi:10.1016/j.ejphar.2011.05.014
   PubMed Web of Science ®Google Scholar
• Sun F, Xie ML, Xue J, Wang HB. Osthole regulates hepatic PPAR alpha-mediated lipogenic gene expression in alcoholic fatty liver murine. Phytomedicine. 2010;17(8–9):669–673. doi:10.1016/j.phymed.2009.10.021
   PubMed Web of Science ®Google Scholar
• Zhang LR, Jiang GR, Yao F, He Y, Liang GQ, Zhang YS, Hu B, Wu Y, Li YS, Liu HY. Growth inhibition and apoptosis induced by osthole, a natural coumarin, in hepatocellular carcinoma. PLoS One. 2012;7(5):e37865. doi:10.1371/journal.pone.0037865
   PubMed Web of Science ®Google Scholar